Mode
Text Size
Log in / Sign up

ADHD and ASD polygenic risk scores correlate with antipsychotic responsiveness in schizophrenia postmortem brains

ADHD and ASD polygenic risk scores correlate with antipsychotic responsiveness in schizophrenia post…
Photo by Markus Winkler / Unsplash
Key Takeaway
Note exploratory, uncorrected associations between ADHD/ASD polygenic risk and antipsychotic response in schizophrenia.

This postmortem brain study included 24 patients with schizophrenia and 48 controls; 19 patients with schizophrenia had antemortem clinical information. The study examined polygenic risk scores (PRSs) for ADHD and ASD as exposures and used controls and high vs low ADHD-PRS groups as comparators. The primary outcome was an antipsychotic responsiveness score (ARS).

For the ARS of positive symptoms (ARS-PS), the results showed a suggestive negative correlation with ADHD-PRS and a positive correlation with ASD-PRS. No correlation was observed for the ARS of general psychopathology or negative symptoms. Gene expression analysis identified 1,773 differentially expressed genes (DEGs), including neuropsychiatric disorder-related genes such as CHRNB2.

Safety and tolerability were not reported. Key limitations include that the associations did not survive multiple testing correction and the sample size was limited. These are exploratory findings with weak evidence strength. Clinicians should interpret these results with caution, as they do not support causal inferences or changes to practice.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
IntroductionSchizophrenia (SCZ) is a highly heritable neuropsychiatric disorder. Its genomic architecture reportedly overlaps with that of neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). However, the effect of genomic risk for ADHD and ASD on SCZ symptoms remains unclear.MethodWe obtained genome-wide association study (GWAS) data from the postmortem brains of 24 patients with SCZ and 48 controls and calculated the polygenic risk scores (PRSs) for ADHD (ADHD-PRS) and ASD (ASD-PRS) using publicly available GWAS data. For 19 patients with SCZ whose antemortem clinical information was available, we conducted correlation analyses between PRSs, severity of SCZ symptoms, and the antipsychotic responsiveness score (ARS). Additionally, we divided the patients into two subgroups based on ADHD-PRS (high and low ADHD-PRS groups) and performed exploratory gene expression analyses and subsequent pathway analysis in the prefrontal cortex.ResultsThe ARS of positive symptoms (ARS-PS) demonstrated a suggestive negative correlation with ADHD-PRS and a positive correlation with ASD-PRS although these associations did not survive multiple testing correction. No correlation was observed between the ARS of general psychopathology or the ARS of negative symptoms and either ADHD-PRS or ASD-PRS. Gene expression analysis identified 1,773 DEGs, including neuropsychiatric disorder-related genes including CHRNB2. These DEGs were enriched in pathways associated with the neuronal system and mitochondrial function.DiscussionOur findings suggest that the genomic risk for neurodevelopmental disorders may affect the antipsychotic responsiveness of patients with schizophrenia and implicate translational alterations in potential marker molecules in this phenotype. Due to the limited sample size in the current study, further investigation on the large cohort is required to verify our exploratory findings.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.